-
explain the molecular variability that can occur between batches of the same biological molecule.
-
describe the importance of identifying and analyzing critical quality attributes for biological molecules.
-
summarize the factors that can affect the immunogenicity of a biologic.
-
distinguish between interchangeability, switching and substitution.
About This Course
The availability of biological medicines has advanced the treatment of many different diseases and conditions. But these complex molecules may represent a challenge for pharmacists, as they are designed, formulated and handled differently from small-molecule medicines.
This 90-minute program aims to increase your familiarity with biologics – and biosimilars in particular – so you can advise and support colleagues and patients who may have questions about these products. It is suitable for Pharmacists, Pharmacologists and Medical Doctors.
The Canadian Council on Continuing Education in Pharmacy has accredited this program for 1.5 CEUs. Le Conseil canadien de l'éducation continue en pharmacie a octroyé 1.5 crédits de formation continue pour ce programme.
This course has a 1-year expiry date of 23rd April 2025. If you complete this course after its expiry date, please double check all claims in this course with up-to-date, peer-reviewed information, as the diagnostic or treatment landscape may have changed.
Expert Reviewers
This course has been made in close collaboration with:
Jatinder Harchowal, MBE FRPharmS
Chief Pharmacist, University College London Hospitals NHS Foundation Trust, UK
Sean Hopkins, BSc(Hon) BSP RPh
Consultant Pharmacist, Canada
Learning Objectives
By the end of this course, you should be able to:
Course curriculum
-
-
Welcome to the Course
-
-
-
Introduction to Precourse Quiz
-
Precourse Quiz
-
-
-
Biologics and Biosimilars - the Basics
-
-
-
Stability, Safety, and Immunogenicity
-
-
-
Evaluating Safety and Efficacy
-
-
-
Introduction to Quiz
-
Final Quiz
-
Course feedback survey
-
About this course
- Free
- 9 lessons
- 0 hours of video content
This course has been supported by an independent medical education grant from Pfizer Inc.